Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962939 | Vaccine | 2016 | 9 Pages |
Abstract
Delaying screening start age and/or extending screening intervals in vaccinated cohorts is likely to be cost-effective. Consideration should be given to both the short- and long-term implications of health policy decisions, particularly for infectious disease interventions that require long time intervals to reach steady state.
Keywords
QALYMOHLTCASCCPPapanicolaouHSILpHuICERLBCSIRSPAPNHANESNHBCervical intraepithelial neoplasiaNational Health and Nutrition Examination SurveyCost-effectiveness analysisCinHigh-riskLow riskQuality-adjusted life yearsCervical cancerliquid based cytologyScreeningIncremental cost-effectiveness ratioVaccinationHuman papillomavirusHuman papilloma virusHPVOhr
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Beate Sander, William W.L. Wong, Man Wah Yeung, Orges Ormanidhi, Karen Atkin, Joan Murphy, Murray Krahn, Shelley L. Deeks,